Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Aralez Pharmaceuticals (T.ARZ) Time to watch It
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GoldenDilemmaon May 11, 2016 12:39pm
78 Views
Post# 24862400

RE:RE:RE:RE:Aralez Pharmaceuticals (T.ARZ) Time to watch It

RE:RE:RE:RE:Aralez Pharmaceuticals (T.ARZ) Time to watch It
Floridas2000 wrote:
Stock Security Description Source Rating Date Previous Rating Current Rating Price Date Previous Target Price Current Target Price
ARZ ARALEZ PHARMACEUTICALS COM Ford Equity Research 06/05/2016 STRONG SELL SELL  



ARLZ is a dog till next year. Even at best case on Yosprala approval... 30,40,50,60+
percent pop from current price? Still quite painful for longs.

Let the market do it's thing and until then holders should place very little relevance on current prices.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities